No products in the cart
What is Insulin-like Growth Factor 1 (IGF-1)?
IGF-1 (Insulin-like growth factor 1), also called somatomedin C, is similar to insulin. It is a hormone that has been shown to play a role in the growth of young mammals and has anabolic effects on adult animals.
It synthesizes as an endocrine hormone and the target organ as a paracrine or autocrine hormone. It is produced throughout one’s lifetime and is highest in animals during adolescence and lowest in babies and the elderly.
Structure of Insulin-like Growth Factor 1 (IGF-1)
It is a small peptide consisting of 70 amino acids with a molecular weight of 7649 Da. The disulfide bonds of IGF-1 link the alpha and beta chains. Rat IGF-1 synthesizes as four precursor isoforms with alternating N-terminal and C-terminal propeptides. Mature IGF-1 is identical between isoforms, and cleavage of the propeptide terminal produces it. There are 12 amino acids in the C-peptide region.
Mechanism of Action
Studies of laboratory animals have shown that IGF-1 is a significant mediator of growth hormone action. The pituitary gland produces Growth Hormone, and it circulates in the bloodstream to cause the liver to produce IGF-1.
IGF-1 binds to at least two of the receptors of cell membrane tyrosine kinases, including the IGF-1 receptor and the insulin receptor. Its main action is binding to the IGF-1 receptor, which is ubiquitous in tissues. This ligand-receptor complex stimulates cell growth and proliferation and emits intracellular messages via the AKT pathway known to inhibit programmed cell death.
Insulin can also bind to the IGF-1 receptor. Still, its affinity is much lower, and IGF-1 can also bind to the insulin receptor to produce a 10% effect of insulin’s potency. Insulin growth factor 1 interacts with all seven IGF-1 binding proteins, specifically IGFBP2 and IGFBP5, and these two serum levels are inversely proportional to circulating IGF-1.
Blood-transported IGF-1 regulates balanced growth across many tissues and organs. Stimulation of autocrine or paracrine IGF-1 can cause excessive growth as it works unaffected by growth hormone.
Insulin-like Growth Factor-1 (IGF-1) Effects
The first demonstration of the growth-stimulating effect of extrinsic IGF-1 occurred by administering a purified hormone to hypophysectomy rats.
● In diabetic rats, it helps control glucose, and efficacy is inversely proportional to the duration of diabetes.
● In vivo administration of IGF-1 showed anabolic effects with subsequent rapid growth in neonatal rats, but there is evidence that complete expression at a given dose requires nutrition.
● Exogenous administration of IGF-1 induced hepatoprotective and antifibrinolytic effects in experimental
cirrhosis. These effects were associated with decreased liver levels of several factors involved in oxidative damage, such as myeloperoxidase and nitric oxide.
● Obstruction of the right middle cerebral artery induces ischemia, and IGF-1 expression in the central nervous system reduces significantly. Intramuscular IGF-1 injection increased expression in the affected muscles, sciatic nerve, lumbar spinal cord, and motor cortex. This reduced neuronal apoptosis and improved motor function.
● Immunohistochemical analysis of rat testes of various ages revealed increased IGF-1 receptors from birth to 20 days after delivery. Tests have shown that IGF reduces the level of Leydig cell apoptosis at all stages of development.
Disclaimer: The products mentioned are not for human or animal consumption. All the information shared in this article is for educational purposes only.
Dr. Usman (BSc, MBBS, MaRCP) completed his studies in medicine at the Royal College of Physicians, London. He is an avid researcher with more than 30 publications in internationally recognized peer-reviewed journals. Dr. Usman has worked as a researcher and a medical consultant for reputable pharmaceutical companies such as Johnson & Johnson and Sanofi.